Bacterin International appointed Robert Di Silvio as president of the company.
Mr. Di Silvio has more than 30 years of experience serving in executive management positions in the medical industry. He most recently served as senior vice president and general manager of the Americas region for Lumenis. As president, Mr. Di Silvio will be responsible for management of sales, marketing and business development.
Bacterin International develops, manufactures and markets biologics products.
More Articles on Devices:
5 Key Results: LDR's Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE's Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018